Ware Conducts AcademyHealth Cyber Seminar Series on Outcomes
Dr. Ware selected
to receive President's Award of the International Society for Quality of Life
Dr. Ware presents at 9th Annual
Health Outcomes Conference (AHOC)
QualityMetric to Improve
Web Sites and Broaden the "SF Community" Based on User Needs
Ware Conducts AcademyHealth Cyber Seminar Series on Health Outcomes
Lincoln, RI. – October 6, 2003 – QualityMetric Incorporated announced today that it's Chief Executive
Officer and Chief Science Officer, John E. Ware, Jr. PhD, will conduct a Cyber Seminar Series entitled
“Advances in Methods for Measuring Health Outcomes from the Patient Point of View” for AcademyHealth.
AcademyHealth is the professional home for health services researchers, policy analysts, and practitioners,
and is a leading, non-partisan resource for the best in health research and policy. This series is being
offered, and Dr. Ware is conducting it, to provide health care professionals with an introduction to the
latest in health services research methods involving the measurement of patient-reported health outcomes
and the practical applications of that in health care.
AcademyHealth Cyber Seminars are offered for a low fee and are open to any interested party. All Cyber
Seminars run from 1:00 - 3:00 p.m. ET. For more information, including full course descriptions and
details on registration, visit www.academyhealth.org/cyberseminars/live.
Monitoring Health Outcomes From the Patient Point of View: Introduction to the Concepts, Methods, and Applications
(Thurs., October 23)
This introductory workshop provides an overview and update of the current state-of-the-art health-related
quality of life (HRQOL) assessment for various applications in the U.S. and internationally. Topics include
the reasons for self-assessment of HRQOL, advances in conceptual frameworks, advantages of generic and
disease-specific measures, and the features of measurement tools that matter most for each application
including: population surveys, clinical trials and outcomes research, disease and risk management, and
improving decision-making at the individual patient level. Next steps in this rapidly evolving field,
including the value of cross-calibrating widely-used health metrics, maintaining forward and backward
comparability of results, other advances in measurement science, and the importance of achieving a
sustainable business model for patient-reported health outcomes, are discussed.
Improving Patient-Reported Health Outcomes Assessments: Computerized Dynamic Health Assessments on the Internet
(Fri., November 21)
This introductory workshop provides an overview of breakthroughs in applications of computerized
adaptive testing (CAT) logic that are revolutionizing generic and disease-specific outcomes
assessment on the Internet, via telephone and using hand-held devices. Implications include "smart"
measures that: are more practical and more responsive to changes over time, substantially reduce
respondent burden, eliminate "ceiling" and "floor" effects over a wide range of severity levels, and
lower data collection costs. A case study of the first and most extensively evaluated CAT-based
functional health assessment on the Internet - the Headache Impact Test (HIT) - will be reviewed
and demonstrated to show how widely-used scales can be cross-calibrated and computerized dynamic
health surveys can be programmed to match their questions to each respondent to provide an immediate
score that can be compared and interpreted regardless of whether the same questions are answered.
Interpreting Health Outcomes From the Patient Point of View: Introduction to the Scoring and Interpretation of Health Outcomes
(Thurs., December 11)
In answer to one of the most common questions in health care - "What do the results mean?" - this
introductory workshop provides an overview of how health outcomes measures should be scored and interpreted.
Published and unpublished examples illustrate the tradeoffs between the options of scoring and interpreting
health profiles versus summary measures. Interpretation guidelines include comparisons with general population
norms, disease-specific benchmarks, clinical and other standards of importance, and results from predictive
studies (e.g., medical expenditures, return to work and work productivity, and mortality). Specific examples
are presented to illustrate the interpretation of results from population surveys, clinical trials and outcomes
research, and individual patient assessments in clinical practice to address the needs of different audiences.
For information on QualityMetric Incorporated,